12 results on '"Benseler, S. M."'
Search Results
2. Predictors of Delayed Referral to a Pediatric Rheumatology Center
- Author
-
Tzaribachev, N., Benseler, S. M., Tyrrell, P. N., Meyer, A., and Kuemmerle-deschner, J. B.
- Published
- 2009
- Full Text
- View/download PDF
3. Acute renal failure in paediatric systemic lupus erythematosus: treatment and outcome
- Author
-
Benseler, S. M., Bargman, J. M., Feldman, B. M., Tyrrell, P. N., Harvey, E., Hebert, D., and Silverman, E. D.
- Published
- 2009
4. Abatacept in difficult-to-treat juvenile idiopathic arthritis
- Author
-
Kuemmerle-Deschner, Jasmin B and Benseler, S M
- Published
- 2008
5. Intra-articular calcifications in a child with juvenile rheumatoid arthritis
- Author
-
Goldman, R D, Benseler, S M, and Schneider, R
- Published
- 2005
6. P2.01 Longitudinal Study of Vascular Markers of Premature Atherosclerosis in Pediatric Systemic Lupus Erythematosus
- Author
-
Bradley, T. J., Tyrrell, P. N., Slorach, C., Ng, L., Nukumizu, L. A., Boros, C. A., Benseler, S. M., and Silverman, E. D.
- Published
- 2008
- Full Text
- View/download PDF
7. Clinical and Molecular Phenotypes of Low-Penetrance Variants of NLRP3: Diagnostic and Therapeutic Challenges.
- Author
-
Kuemmerle‐Deschner, J. B., Verma, D., Endres, T., Broderick, L., Jesus, A. A., Hofer, F., Blank, N., Krause, K., Rietschel, C., Horneff, G., Aksentijevich, I., Lohse, P., Goldbach‐Mansky, R., Hoffman, H. M., and Benseler, S. M.
- Subjects
ENZYME metabolism ,TREATMENT effectiveness ,CELL death ,EYE diseases ,FEVER ,GENETIC disorders ,HEARING disorders ,INFLAMMATION ,INTERLEUKINS ,KIDNEYS ,MEDICAL cooperation ,RESEARCH ,SKIN diseases ,PHENOTYPES ,DNA-binding proteins ,STATISTICAL significance ,DESCRIPTIVE statistics ,CHEMICAL inhibitors - Abstract
Objective Cryopyrin-associated periodic syndromes ( CAPS) result from gain-of-function mutations in the NLRP3 gene, which causes excessive release of interleukin-1β ( IL-1β) and systemic inflammation. While pathogenetic NLRP3 variant phenotypes are well-characterized, low-penetrance NLRP3 variants represent a significant clinical challenge. The aims of this study were to determine the clinical phenotype, the in vitro biologic phenotype, and the effect of anti- IL-1 treatment in patients with low-penetrance NLRP3 variants. Methods A multicenter study of consecutive symptomatic patients with low-penetrance NLRP3 variants recruited from 7 centers between May 2012 and May 2013 was performed. The observed findings were transferred into a study database, from which they were extracted for analysis. Controls were patients with a known pathogenetic NLRP3 variant. Clinical presentation and CAPS markers of inflammation were captured. Functional assays of inflammasome activation, including caspase 1 activity, NF-κB release, cell death, and IL-1β release, were performed. Treatment effects of IL-1 were determined. Comparisons between low-penetrance and pathogenetic NLRP3 variants were performed. Results The study included 45 patients, 21 of which were female (47%); 26 of the patients (58%) were children. NLRP3 low-penetrance variants identified in the patients were Q703K (n = 19), R488K (n = 6), and V198M (n = 20). In the controls, 28 had pathogenetic NLRP3 variants. Patients with low-penetrance NLRP3 variants had significantly more fever (76%) and gastrointestinal symptoms (73%); eye disease, hearing loss, and renal involvement were less common. Functional inflammasome testing identified an intermediate phenotype in low-penetrance NLRP3 variants as compared to wild-type and pathogenetic NLRP3 variants. All treated patients responded to IL-1 inhibition, with complete response documented in 50% of patients. Conclusion Patients with low-penetrance NLRP3 variants display a distinct clinical phenotype and an intermediate biologic phenotype, including IL-1β and non- IL-1β-mediated inflammatory pathway activation. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
8. Neuropsychiatric involvement in pediatric systemic lupus erythematosus.
- Author
-
Benseler, S. M. and Silverman, E. D.
- Subjects
- *
PEDIATRIC neuropsychiatry , *NEUROPSYCHIATRY , *BIOLOGICAL psychiatry , *SYSTEMIC lupus erythematosus , *AUTOIMMUNE diseases , *PSYCHOSES - Abstract
Neuropsychiatric (NP) manifestations are found in approximately 25% of children and adolescents with pediatric SLE (pSLE). In 70% of those, NP involvement will occur within the first year from the time of diagnosis. Headaches (66%), psychosis (36%), cognitive dysfunction (27%) and cerebrovascular disease (24%) are the most common presentations. The support of a psychiatrist is often required. Anti-phospholipid antibodies are associated with distinct NP disease entities and may be implicated in the pathogenesis of several manifestations of NP-pSLE including chorea, cerebrovascular disease and seizures. The role of novel auto-antibodies and imaging modalities is currently explored. The treatment of NP-pSLE is not based on prospective studies; however, an immunosuppressive combination therapy consisting of high doses of prednisone and a second line agent such as cyclophosphamide or azathioprine is commonly suggested for children with NP-pSLE. The role of novel therapies is currently studied. The outcome of children with NP-pSLE is relatively good. The overall survival is 95–97%, 20% of children experience a disease flare during childhood and 25% have evidence of permanent neuropsychiatric damage. [ABSTRACT FROM AUTHOR]
- Published
- 2007
- Full Text
- View/download PDF
9. Leflunomide is associated with a higher flare rate compared to methotrexate in the treatment of chronic uveitis in juvenile idiopathic arthritis.
- Author
-
Bichler J, Benseler SM, Krumrey-Langkammerer M, Haas JP, and Hügle B
- Subjects
- Child, Child, Preschool, Chronic Disease, Cohort Studies, Dose-Response Relationship, Drug, Drug Therapy, Combination, Female, Humans, Infant, Leflunomide, Male, Recurrence, Retrospective Studies, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha antagonists & inhibitors, Antirheumatic Agents therapeutic use, Arthritis, Juvenile complications, Isoxazoles therapeutic use, Methotrexate therapeutic use, Uveitis drug therapy, Uveitis etiology
- Abstract
Objectives: Chronic anterior uveitis is a serious complication of juvenile idiopathic arthritis (JIA); disease flares are highly associated with loss of vision. Leflunomide (LEF) is used successfully for JIA joint disease but its effectiveness in uveitis has not been determined. The aim of this study was to determine whether LEF improves flare rates of uveitis in JIA patients compared to preceding methotrexate (MTX) therapy., Method: A single-centre retrospective study of consecutive children with JIA and chronic anterior uveitis was performed. All children initially received MTX and were then switched to LEF. Demographic, clinical, and laboratory data, dose and duration of MTX and LEF therapy, concomitant medications and rate of anterior uveitis flares, as determined by an expert ophthalmologist, were obtained. Flare rates were compared using a generalized linear mixed model with a negative binomial distribution., Results: A total of 15 children were included (80% females, all antinuclear antibody positive). The median duration of MTX therapy was 51 (range 26-167) months; LEF was given for a median of 12 (range 4-47) months. Anti-tumour necrosis factor (anti-TNF-α) co-medication was given to four children while on MTX. By contrast, LEF was combined with anti-TNF-α treatment in six children. On MTX, JIA patients showed a uveitis flare rate of 0.0247 flares/month, while LEF treatment was associated with a significantly higher flare rate of 0.0607 flares/month (p = 0.008)., Conclusions: Children with JIA had significantly more uveitis flares on LEF compared to MTX despite receiving anti-TNF-α co-medication more frequently. Therefore, LEF may need to be considered less effective in controlling chronic anterior uveitis.
- Published
- 2015
- Full Text
- View/download PDF
10. Development of a standardized MRI scoring tool for CNS demyelination in children.
- Author
-
Verhey LH, Branson HM, Laughlin S, Shroff MM, Benseler SM, Feldman BM, Streiner DL, Sled JG, and Banwell B
- Subjects
- Acute Disease, Adolescent, Child, Consensus, Diagnosis, Differential, Encephalomyelitis, Acute Disseminated pathology, Female, Humans, Magnetic Resonance Imaging statistics & numerical data, Male, Multiple Sclerosis pathology, Observer Variation, Predictive Value of Tests, Reference Standards, Registries, Reproducibility of Results, Severity of Illness Index, Vasculitis, Central Nervous System pathology, Central Nervous System pathology, Demyelinating Diseases pathology, Magnetic Resonance Imaging methods, Magnetic Resonance Imaging standards
- Abstract
Background and Purpose: The degree to which MR imaging is useful in the diagnosis of MS is predicated on standardized and reliable evaluation of MR imaging parameters. We aimed to devise items for an MR imaging scoring tool that would have high inter-rater agreement and would be straightforward to apply., Materials and Methods: On the basis of a literature search and consensus of an expert panel, we identified 48 parameters that describe acute CNS demyelination, predict MS diagnosis, or characterize demyelinating disorder mimics. MR images of children with clinically confirmed MS, monophasic ADEM, and angiography-negative biopsy-positive small-vessel primary angiitis of the CNS were scored by 2 neuroradiologists independently, using the preliminary 48-parameter tool. Parameters with Cohen κ ≥ 0.6 and deemed important in predicting diagnosis were retained. Parameters not visualized on routine clinical imaging or not important in differentiating MS, ADEM, and SV-cPACNS were discarded., Results: Of 65 eligible patients, 55 children were enrolled (16 with monophasic ADEM, 27 with MS, 12 with SV-cPACNS); 10 were excluded (6 had hard-copy films, 4 did not meet MR imaging quality requirements). Of the 48 parameters, 16 were retained in the final scoring tool. The remaining 28 parameters were discarded: 4 had κ < 0.6 and were not deemed useful in predicting diagnosis; 9 were not visible on routinely acquired clinical images; and 15 had inter-rater agreement ≥0.6 but were not useful in differentiating monophasic ADEM, MS, and SV-cPACNS., Conclusions: We propose a 16-parameter MR imaging scoring tool that is straightforward to apply in the clinical setting and demonstrates high inter-rater agreement.
- Published
- 2013
- Full Text
- View/download PDF
11. Angiography of primary central nervous system angiitis of childhood: conventional angiography versus magnetic resonance angiography at presentation.
- Author
-
Aviv RI, Benseler SM, DeVeber G, Silverman ED, Tyrrell PN, Tsang LM, and Armstrong D
- Subjects
- Adolescent, Cerebral Arteries pathology, Child, Child, Preschool, Cohort Studies, Constriction, Pathologic diagnosis, Female, Humans, Infant, Male, Sensitivity and Specificity, Statistics as Topic, Cerebral Angiography, Image Processing, Computer-Assisted, Imaging, Three-Dimensional, Magnetic Resonance Angiography, Vasculitis, Central Nervous System diagnosis
- Abstract
Background and Purpose: To systematically analyze conventional angiographic (CA) features of children with primary central nervous system angiitis (cPACNS), to compare and correlate CA and MR angiography (MRA) lesion characteristics, and to define the sensitivity and specificity of MRA with CA as a reference standard., Methods: A retrospective, single-center cohort study of consecutive patients with cPACNS was performed. Patients with CA and MRA studies at diagnosis were included. Imaging studies were blindly reviewed by 2 neuroradiologists using a standard analysis protocol. CA and MRA studies were compared using nonparametric analysis., Results: Of 45 patients with MRA at diagnosis, there were 25 for whom CA and MRA studies were performed within 1 month of each other. These comprised the study group. The CA distribution of lesions was multifocal (76%) and proximal (86%) (P < .05) with a trend toward unilaterality (P = .06) with anterior circulation involvement (P = .08). The sensitivity and specificity of MRA for CA abnormality was 70% and 98%, respectively. There was no significant difference between MRA and CA for lesion detection or characterization (P = .87), and the modalities showed a fair correlation (kappa = 0.4)., Conclusion: Angiographic lesions are multifocal and occur proximally and unilaterally within the anterior circulation. There is no significant difference in the ability of MRA to detect and characterize lesions when compared with CA.
- Published
- 2007
12. MR imaging and angiography of primary CNS vasculitis of childhood.
- Author
-
Aviv RI, Benseler SM, Silverman ED, Tyrrell PN, Deveber G, Tsang LM, and Armstrong D
- Subjects
- Adolescent, Brain pathology, Cerebral Arteries pathology, Child, Child, Preschool, Female, Humans, Infant, Magnetic Resonance Angiography, Male, Magnetic Resonance Imaging, Vasculitis, Central Nervous System diagnosis
- Abstract
Background and Purpose: Primary angiitis of the central nervous system of childhood (cPACNS) is a rare and ill-defined disease. In the absence of a brain biopsy, the diagnosis is based on typical clinical and imaging abnormalities. The aim of this study was to analyze systematically the MR imaging and MR angiographic (MRA) abnormalities in a large cohort of children with cPACNS., Methods: We analyzed the MR imaging features of a single pediatric center cohort of 45 cPACNS patients. MR imaging studies were performed for all patients, and both MR imaging and MRA were performed for 42 patients, who formed the cohort for review of the presence and correlation of lesions. Proportions were calculated by using the Fisher exact test, and agreement between MR imaging and MRA was calculated by using the McNemar test. The sensitivity of each diagnostic technique was established., Results: The most-common pattern of parenchymal abnormality was multifocal, unilateral involvement, each in 42/45 patients (93%). The lateral lenticulostriate artery terrritory was affected in 56% of cases, with involvement of a supratentorial deep gray matter structure in 91%. No infratentorial lesion occurred in the absence of supratentorial abnormality. MRA was normal in 12/42 patients (28.6%). Among the abnormal studies, stenosis was detected on MRA in 83% and was "benign" in appearance in 73% of patients and "aggressive" in 16.7%. Involvement was proximal in 83% and distal in 27% of patients. Multiple ipsilateral lesions were seen in 63%. MR imaging was abnormal in every patient where MRA was abnormal. With the assumption of MR imaging as the gold standard, the sensitivity of MRA was 72%. The agreement between MR imaging and MRA for abnormality was significant (P = .04)., Conclusion: We have illustrated the MR imaging and MRA appearances of cPACNS in the largest cohort to date. Both parenchymal and vascular lesions were predominantly proximal, unilateral, and multifocal within the anterior circulation. There was good agreement between MR imaging and MRA for lesion location. MR imaging findings were abnormal in all cases at diagnosis, and this remains the most sensitive technique to the detection of vasculitis.
- Published
- 2006
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.